Faeth Therapeutics, Inc.
FTHCIK 0001829802 · last filing Jul 1, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
13,634 bought / 0 sold
net +13,634 sh · +$326.1K
- buys
- 6
- sells
- 0
- insiders active
- 1
Filing tape
Filed Wed, Jul 1, 2026
- +13,634 sh · $326.1K
Stephenson Brian C — Chief Financial Officer
- Bought831Common Stock@ $23.34→ 33,885 held
- Bought1,910Common Stock@ $22.95→ 35,795 held
- Bought1,638Common Stock@ $23.88→ 37,433 held
- Bought4,255Common Stock@ $24.98→ 41,688 held
- Bought4,400Common Stock@ $23.40→ 46,088 held
- Bought600Common Stock@ $24.22→ 46,688 held
Insiders on this tape
- Stephenson Brian CChief Financial Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.